Targeting angiogenesis from premalignancy to metastases
- PMID: 19336719
- PMCID: PMC10031626
- DOI: 10.1158/1940-6207.CAPR-09-0032
Targeting angiogenesis from premalignancy to metastases
Comment on
-
Sunitinib prolongs survival in genetically engineered mouse models of multistep lung carcinogenesis.Cancer Prev Res (Phila). 2009 Apr;2(4):330-7. doi: 10.1158/1940-6207.CAPR-08-0213. Epub 2009 Mar 31. Cancer Prev Res (Phila). 2009. PMID: 19336729 Free PMC article.
References
-
- Folkman J, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989;339:58–61. - PubMed
-
- Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86:353–64. - PubMed
-
- Fontanini G, Calcinai A, Boldrini L, et al. Modulation of neoangiogenesis in bronchial preneoplastic lesions. Oncol Rep 1999;6:813–7. - PubMed
-
- Merrick DT, Haney J, Petrunich S, et al. Overexpression of vascular endothelial growth factor and its receptors in bronchial dypslasia demonstrated by quantitative RT-PCR analysis. Lung Cancer 2005;48:31–45. - PubMed
-
- Bergers G, Javaherian K, Lo KM, Folkman J, Hanahan D. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 1999;284:808–12. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
